Picture of Nyxoah SA logo

NYXH — Nyxoah SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: FDA Approves Genio 2.1 For Use In Dream U.S. Ide Pivotal Study

June 1 (Reuters) - 
    * FDA APPROVES GENIO® 2.1 FOR USE IN DREAM U.S. IDE PIVOTAL
STUDY

Source text for Eikon:  ID:nGNXz16C8 
Further company coverage:  NYXH.BR

Recent news on Nyxoah SA

See all news